Weekly Quick Hits (Research Triangle Park) – Week of May 8, 2023

Published on : Published by : BioBuzz Media

Weekly Quick Hits (Research Triangle Park) – Week of May 8, 2023 By Alex KeownMay 12, 2023 Funding, Awards and Collaborations Humacyte Secures $160 Million in Funding from Oberland Capital [….]

Weekly Quick Hits (Research Triangle Park) – Week of April 3, 2023

Published on : Published by : BioBuzz Media

Weekly Quick Hits (Research Triangle Park) – Week of April 3, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodApril 7, 2023 Funding, Awards and Collaborations Sciencix Named SBA Exporter [….]

Fennec Pharmaceuticals Eyes Potential EU Approval of Pedmark to Treat Chemotherapy-associated Hearing Loss in Younger Patients

Published on : Published by : Alex Keown

Fennec Pharmaceuticals continues to build out its Pedmark commercial team in anticipation of potential approval in Europe following a recommendation for approval from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on March 31.